Treatment of Zollinger-Ellison Syndrome

首次发布于 1999 年 11 月 4 日

Personalized Cancer Care at Cedars-Sinai Medical Center Samuel Oschin Comprehensive Cancer Institute

计划入组 52 人 · 首次发布于 2017 年 4 月 4 日

Image and Dosimetry Related Research of Department of Medical Physics, Cross Cancer Institute

计划入组 40 人 · 首次发布于 2006 年 4 月 14 日

Filgrastim biosimilar (Institute of Medical Biology Chinese Academy of Medical Sciences)

Multiple Myeloma-specific universal CAR T cells(Shenzhen Geno-Immune Medical Institute)

Tetranectin-specific monoclonal antibodies (Feinstein Institute for Medical Research)

The Gaia Medical Institute, LLC

United States

Rehman Medical Institute

Pakistan

Kenya Medical Research Institute

Kenya

Ellison Medical Institute and UniQuest Partner to Advance First-in-Class TRPV6-Targeting Therapy for Resistant Prostate Cancer

Salt AI Secures $10 Million to Advance Contextual AI Platform for Life Sciences

Global Review of Zollinger-Ellison Syndrome Clinical Trials Reveals Key Trends